Genotropin and Oxycodone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Genotropin (somatropin recombinant) and Oxycodone (oxycodone hydrochloride). Common drug interactions include fall among females and renal cancer among males.

The phase IV clinical study analyzes what interactions people have when they take Genotropin and Oxycodone. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Genotropin?

Genotropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 41,924 Genotropin users. Check the latest studies of Genotropin.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.



On Jul, 27, 2026

51 people who take Genotropin and Oxycodone together, and have interactions are studied.

Genotropin and Oxycodone drug interactions.

What are the common drug interactions of Genotropin and Oxycodone, by gender? *:

female:

  1. Fall
  2. Injury
  3. Vertigo
  4. Wrist fracture
  5. Connective tissue disorder (any disease that has the connective tissues of the body)
  6. Flatulence (flatus expelled through the anus)
  7. Immunosuppression
  8. Infection
  9. Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
  10. Therapeutic response unexpected

male:

  1. Renal cancer (cancer of kidney)
  2. Back disorder
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Muscle atrophy (a decrease in the mass of the muscle)
  5. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Peripheral swelling
  8. Drug ineffective
  9. Hospitalisation
  10. Meningitis bacterial (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)

What are the common drug interactions of Genotropin and Oxycodone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Arthralgia (joint pain)
  2. Arthropathy
  3. Joint stiffness
  4. Spinal pain (pain in spine)
  5. Fatigue (feeling of tiredness)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Sleep disorder
  8. Tibia fracture (fracture of lower leg bone)
  9. Second primary malignancy (after getting cure a cancer, a new cancer development)
  10. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)

20-29:

n/a

30-39:

  1. Hospitalisation
  2. Agitation (state of anxiety or nervous excitement)
  3. Craniocerebral injury (injury to cranium and brain)
  4. Hepatic enzyme increased
  5. Migraine (headache)
  6. Overdose
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  8. Snoring
  9. Suicidal ideation
  10. Suicide attempt

40-49:

  1. Therapeutic response unexpected
  2. Arthralgia (joint pain)
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Crying
  5. Depression
  6. Influenza like illness
  7. Injection site haemorrhage (bleeding from injection site)
  8. Injection site pain
  9. Pruritus (severe itching of the skin)
  10. Pyrexia (fever)

50-59:

  1. Headache (pain in head)
  2. Alopecia (absence of hair from areas of the body)
  3. Alveolar osteitis (complication of wound healing following extraction of a tooth)
  4. Asthenia (weakness)
  5. Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
  6. Burning sensation
  7. Drug ineffective
  8. Fatigue (feeling of tiredness)
  9. Hot flush (sudden feelings of heat)
  10. Hypersomnia (excessive daytime sleepiness (eds))

60+:

  1. Bone disorder
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Cardiomegaly (increased size of heart than normal)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Peripheral swelling
  8. Dizziness
  9. Meningitis bacterial (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

What are the existing conditions these people have? *

  1. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 12 people, 23.53%
  2. Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 10 people, 19.61%
  3. Stress And Anxiety: 10 people, 19.61%
  4. Sleep Disorder: 8 people, 15.69%
  5. Depression: 8 people, 15.69%
  6. Secondary Hypothyroidism (pituitary gland and its failure to secrete tsh): 7 people, 13.73%
  7. Neck Pain: 7 people, 13.73%
  8. Thyroid Diseases: 7 people, 13.73%
  9. Migraine (headache): 7 people, 13.73%
  10. Vitamin B12 Deficiency: 6 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Genotropin and Oxycodone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Genotropin and Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Genotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Genotropin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycodone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant and oxycodone hydrochloride (the active ingredients of Genotropin and Oxycodone, respectively), and Genotropin and Oxycodone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: